Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Five Treatments in Patients With Plantar Warts

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female patient aged 18 years or more.~* Clinical evaluation~* Number of warts lower than 10 on the 2 feet and total diameter of warts lower than 10 cm, whether previously treated or not~* In treated patients, all potentially active treatment on warts since at least one month should be stopped.~* Effective contraception for women of childbearing age~* Immunocompetent patients~* Patient with one or more warts on soles and board feet.~  * MYRMECIE : rounded warts, deep, covered with a stratum corneum more or less thick; after stripping, appear black points, very specific; often painful to pressure. They are lonely, single or not. They could regroup galley thick. The stripping can them to individualize.~ * Mosaic : plate small warts, superficial, often sitting on the heel or Forefoot. Little painful, they are often ignored by the patients when they appear~* Patient affiliated to the French social security.~Exclusion Criteria:~* Patient suspected to be immunocompromised~* Patient aged under 18 years~* Patient refusing to sign the consent~* Pregnant or lactating women~* Plantar calluses~* Known hypersensitivity to imiquimod (Aldara®) or any excipients of the cream (isostearic acid, benzyl alcohol, cetyl alcohol, stearyl alcohol, paraffin, polysorbate 60, sorbitan stearate, glycerol, methyl hydroxybenzoate, propyl hydroxybenzoate, xanthan gum, purified water)~* Known hypersensitivity to 5 fluoro-uracil (Efudix®) or any excipients of gel (stearyl alcohol, Vaseline, polysorbate 60, propyleneglycol, purified water - conservatives: METHYL PARAHYDROXYBENZOATE, PROPYL PARAHYDROXYBENZOATE)~* Contra-indication to Pomade M.O Cochon® (Known allergy to any components)~* Known hypersensitivity to Blenderm®~* Extra plantar concomitant warts (to exclude risk of endogenous recontamination by an extra plantar site)~* Plantar hyperhidrosis making impossible adhesion of plaster.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Salicylate ointment (Type: EXPERIMENTAL): Salicylate ointment under occlusion (pomade M.O Cochon®)
- Imiquimod (Type: EXPERIMENTAL): Imiquimod : Aldara®
- 5-fluoro-uracil (Type: EXPERIMENTAL): 5-fluoro-uracil cream : Efudix®
- Cryotherapy (Type: EXPERIMENTAL): liquid nitrogen : Cryotherapy

Based on this trial design, predict the completion outcome and termination type (if applicable).